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(Table). This association was stronger in women than in men (PzO.02 for interaction). 
Conclusion. Depression is associated with poorer functional benefits after CABG, partic- 
ularly in women. 
JACC March 19,2003 
Caucasians (CA, 31% females, p<O.OoOl) underwent 5560 PCls and 10384 CABG prc- 
cedures. Gender (p=O.l22) and race (p=O.641) had no significant impact on the choice of 
procedure. There were 397 (2.5% of 15994 patients) in-hospital post-procedural fatali- 
ties. Mortality rates were similar in AA and CA but significantly higher in women (3.3% 
versus 2.1% in men. p<O.OOOl). Within race analysis showed no effect of gender on mor- 
tality in all AA patients and in PCI or CABG groups separately. However, in-hospital mor- 
tality in CA women was 50% higher than in CA men (163/4865 versus 226/10700, 
p<O.OOOl). This mortality excess was observed only in CABG patients (4.2% in CA 
women versus 2.6% in CA men. p<O.OOOl). Detrimental effect of female gender on in- 
hospital mortality remained unchanged when outcomes were adjusted by age, diabetes, 
hypertension, congestive heart failure, and smoking history. 
Conclusion: In a large all-inclusive cohort of patients with coronary artery disease past- 
revascularization mortality was not affected by race. However, white women undergoing 
CABG incurred a 50% higher mortality than men. This gender-related increase in mortal- 
ity was independent of age, diabetes, and other co-morbidities. 
All Patients Man Women 
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R Cl Trend R Cl Trend R Cl Trend 
No Depressfon 1 0.005 1 _ ~ 0.17 t- 0.006 
Mild Depression 1. 0.9. 1. 0.8. 1. 0.6 
4 2.3 5 2.9 3 3.0 
Definite 2. 1.3. 1. 0.6- 5. 1.6- 
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1144-56 Multivariate Analysis of 2,300 Patients Demonstrates 
Minimal Influence of Obesity on Outcomes for Coronary 
Bypass Surgery 
Louis I. Astra, Thomas E. Williams, Robert E. Michler. Ohio State University, Columbus, 
OH 
Background Obesity has been shown in multiple studies to result in additional risk 
of adverse outcomes in those undergoing coronary bypass surgery. In fact, obesity is 
used as an independent predictor of risk in several risk assessment scores including 
the Parsonnet and STS models. Our study examines the experience at Ohio State 
University to determine the effect of obesity on outcome. 
Methods: All patients that underwent isolated coronary bypass procedures, including 
reoperations, between January 1997 and June 2002 were examined retrospectively. 
A total of 2,334 procedures were performed. Of those, 296 patients were obese 
(BMI>=35, range 35.0-75.2, mean 40.2) and the remaining 2,026 patients acted as 
controls (BMlc35, range 16.3-34.9, mean 27.2). The obese group was compared to 
the controls with respect to age, gender, diabetes, history of myocardial infarction, 
and NYHA functional class. Survival and potential complications including sternal 
infections, pulmonary complications (pneumonia, ARDS. pulmonary embolus, 
prolonged ventilatory assistance), cerebrovascular events, and bleeding were then 
analyzed in a multivariate fashion. 
Results: (See Table)Of the preoperative variables, the only significant difference 
was gender, with the obese group having more females. No significant difference 
was found in perioperative mortality. There was also no difference in the frequency of 
reoperative surgery between groups. The only significant difference in morbidity was 
with superficial sternal wound infections, with the obese population having a higher 
risk. Of the remaining prelpostoperative variables, diabetes and postoperative 
bleeding approached statistical significance with obese patients more likely to be 
diabetic, and less likely to require blood transfusions. 
Conclusions Obesity is not an independent risk factor of survival in coronary 
bypass surgery. This study also demonstrates that obesity has minimal impact on 
outcomes, with the only effect being supedicial sternal infections. 
Patient and Outcome Analysis 
Variable Obase(BMI>=35) Controls (BMlr30) P value 
Male, % 53.0 72.0 <.OOOl 
Age (mean), Y 63.0 64.1 .6025 
Mortality, % 1.7 2.5 .4624 
Superficial Sternal, Infections, % 3.4 0.5 <.0001 
Deep Sternal Infections 0.7 0.5 .9355 
CVA (pertoperative), % 0.5 0.05 .6061 
Requiring blood transfusions, % 63.6 69.0 .0741 
1144-57 Outcomes in Coronary Revascularization Procedures: 
Race Is Less Important Than Gender 
Mikhail Torosoff, Robert D. Millar, Steven A. Fein, Jan L. Houghton, Edward F. Philbin. 
Ill, Albany Medical College, Albany, NY 
Background: Current literature suggests race and gender-related disparities in cardiovas- 
cular care delivery. Effects of gender and race on the outcomes of coronary revascular- 
ization procedures are debated. In addition, clinical outcomes of revascularization are 
potentially confounded by the selection bias when higher risk patients undergo lower risk 
procedures. To minimize this bias, we reviewed in-hospital outcomes in an all-inclusive 
cohort of patients undergoing any coronary revascularization procedures during the 
selected time period. 
Methods: All patients treated with coronary artery bypass grafting (CABG) or percutane- 
ous coronary intervention (PCI) at a tertiary medical center during 1997-2001 were 
included in the study. Contingency, ANOVA, and logistic regression analyses were 
employed to evaluate the determinants of in-hospital modality 
Results: During the study period, 379 African-Americans (AA, 44% females) and 15565 
1144-58 Intra- and Post-Operative Treatment end Course 
Variables Associated With Stroke Subtypes Following 
Coronary Artery Bypass Graft Surgery 
Donald S. Likosky, Steven P. Braff, Gregg S. Hartman, Eric S. Landis, Louis R. Caplan, 
Ronald M. Weintraub, Brett I. Applebaum, Cathy S. Ross, Gerald T. O’Connor, Northern 
New England Cardwascular Disease Study Group, Lebanon, NH 
Background: We previously determined that embolic and hypoperfusion strokes 
accounted for 62% and 9% of all strokes secondary to CABG surgery, respectively. In 
this study we quantified the association between intra- and post-operative factors and the 
risk of etiologic stroke subtypes. 
Methods We conducted a prospective cohort study of 26,009 patients undergoing iso- 
lated CABG surgery from 1992-2000. Etiology was classified as: embolic, hypoperfusion, 
or other. These analyses focused on the first two subgroups due to their homogeneity. 
Embolic strokes were defined as ischemic strokes with one of three likely sources of 
thrombus: aortic, cardiac or carotid. Hypoperfusion strokes were defined as strokes due 
to a mixture of extracranial stenoses and/or systemic hypotension. Odds ratios were 
adjusted for age, gender, diabetes, vascular disease, renal failure, acuity, ejection frac- 
tion. Those without strokes were the reference group for odds ratios. 
Results: Atrial fibrillation was significantly associated with embolic (OR 2.4, Cl ss-,- 1.6 - 
3.2, p<O.OOl) and hypoperfusion strokes (OR 5.4, Cl s5% 2.2 - 13.7, p<O.OOl). Patients 
having cardiopulmonary bypass duration greater than 120 minutes, versus less than 60 
minutes, had a 1.5-fold (Cl s5% 0.6 - 2.5, ptrend 0.03) risk of embolic, and a 6.4-fold 
(Cl ssx 0.8 - 52.0, ptrend 0.01) risk of hypoperfusion strokes. 
Conclusion: After adjusting for preoperative factors, post-operative atrial fibrillation and 
duration of cardiopulmonary bypass remained significant predictors of both embolic and 
hypopelfusion strokes. Prevention and management of atrial fibrillation and attention to 
prolonged exposure to extracorporeal circulation may offer leverage areas for the 
improvement of stroke outcomes. 
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1169-51 People at Increased Risk of Cardiovascular Disease 
Screened for the NAVIGATOR Trial Frequently Have 
Undiagnosed Diabetes or Impaired Glucose Tolerance 
Robelt M. Califf, Rury Holman, on behalf of the Navigator Trial Steering Committee and 
Investigators, Duke Clinical Research Institute, Raleigh, NC, Oxford Centre for Diabetes, 
Endocrinology and Metabolism, Oxford, United Kingdom 
Background: Impaired glucose tolerance (IGT) and type 2 diabetes (T2DM) increase the 
risk of cardiovascular disease (CVD) 2-4 fold. NAVIGATOR (Nateglinide and Valsartan in 
IGT Outcomes Research) is a multinational, randomized, placebo-controlled, double- 
blind, 2x2 factorial design trial investigating whether progression to T2DM or new CVD 
events can be reduced by nateglinide and/or valsartan. 7500 individuals SO y with CVD 
or ~555 v with risk factors for CVD and with IGT are beina recruited. Results: Of the 7215 
people screened by August 2002, man and women were equally represented, most were 
Caucasian 181%) with mean f*lSD) bodv mass index 30+6 kc/m* and 1546 have been 
I  ,  _  
randomised. The prevalence of impaired fasting glucose (IFG), IGT and TPDM did not 
differ between those with risk factors for CVD and those who had already had a CVD 
event. Only a minority had normal glucose tolerance (NGT): 
255~ + risk factors 
~50~ + CVD 
” Age NGT IFG IGT DM 
4946 64i6 30.4% 11.6% 30.7% 27.2% 
1963 63+8 31 .O% 12.3% 28.9% 27.6% 
Conclusion: These results suggest that, in people at increased risk for CVD, diabetes is 
frequently undiagnosed and that IGT is common. Oral glucose tolerance testing should 
